BioSpace News Archive

Praedicare Inc. today announced it has been awarded a two-year, $2.8 million grant by the Bill & Melinda Gates Foundation to evaluate novel TB drug regimens using Praedicare’s in vitro hollow fiber model of Tuberculosis (TB) in identifying potential new drug regimens that shorten treatment times for the disease.

nference today announced publication of a study in the Journal of Stroke and Cerebrovascular Diseases,

Onconova Therapeutics, Inc. today announced the publication of a preclinical study in the journal Molecular Cancer.

Surrozen Inc. announced today that data from preclinical studies were presented in four oral Abstract Flash Talk presentations during The Liver Biology Conference.

Entera Bio Ltd. today announced the European Patent Office has granted a patent titled “Methods and Compositions for Oral Administration of Proteins”

Vor Biopharma announced that it will build-out an in-house clinical manufacturing facility in Cambridge, Massachusetts to support its development of potentially transformative engineered hematopoietic stem cell and chimeric antigen receptor T-cell therapeutic candidates for patients with hematological malignancies.

Eli Lilly and Company (NYSE: LLY) launched Think Talk Treat Migraine™, a new initiative to empower people living with migraine and their primary care providers to recognize key symptoms of migraine and have better conversations about the disease that can lead to proper diagnosis and treatment.

Lineage Announces Exclusive Option Agreement With Amasa Therapeutics for Supply and Use of Clinical-Grade Hystem,

KIYATEC, Inc . announced today the publication of new peer-reviewed data that establishes clinically meaningful prediction of patient-specific responses to standard of care therapy, prior to treatment, in newly diagnosed glioblastoma (GBM).

PhaseBio to host conference call today at 5:30 am PST / 8:30 am EST that it has entered into an exclusive licensing agreement with Alfasigma S.p.A.